There are 2867 resources available
667P - Updated efficacy and safety of larotrectinib in patients with TRK fusion salivary gland tumours
Presenter: David S Hong
Session: Poster session 09
668P - Comprehensive analysis of the tumor immune microenvironment (TIM) in advanced adenoid cystic (ACC) and non-adenoid cystic salivary gland cancers (SGC)
Presenter: Damian Rieke
Session: Poster session 09
669P - Neoadjuvant chemotarget therapy with cetuximab, docetaxel, and cisplatin in locally advanced resectable oral/oropharygeal squamous cell carcinoma: A multicenter phase III trial (Eagle trial)
Presenter: Lai-ping Zhong
Session: Poster session 09
670P - Discordant pathologic tumor response in primary tumors and lymph nodes after neoadjuvant immune checkpoint inhibition (ICI) in head and neck squamous cell carcinoma (HNSCC)
Presenter: Adam Luginbuhl
Session: Poster session 09
671P - Postoperative chemoradiation in combination with cetuximab followed by 6-months cetuximab maintenance in squamous cell carcinoma of the head and neck with high risk of locoregional recurrence
Presenter: Bálint Tamaskovics
Session: Poster session 09
673P - A prospective comparative study on biweekly docetaxel, cisplatin, 5-fluorouracil, leucovorin (TPFL) versus triweekly TPF as an induction chemotherapy in locally advanced squamous cell carcinoma of head and neck
Presenter: Sreevalli Anantharamu
Session: Poster session 10
674P - Initial curative management for localized/locally advanced head and neck squamous cell carcinomas (LAHNSCC): Exclusive (chemo)radiation (CRT) or S/IC (surgery or induction chemotherapy) – The EPOCKS study
Presenter: Jérome Fayette
Session: Poster session 10
675P - Patterns of radiological responses to anti-PD1 in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) in TOPNIVO (T) study
Presenter: Caroline Even
Session: Poster session 10
676P - ATHENA: A multicenter phase II of atezolizumab (A) and bevacizumab (B) in patients (pts) with recurrent or metastatic squamous-cell carcinoma of the head and neck (R/M HNSCC) - The HPV-negative cohort
Presenter: Jérome Fayette
Session: Poster session 10